Found 533 matching trials
TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor PHASE1 To evaluate safety, tolerance and efficacy of TASO(TGF-ฮฒ2 targeting anti-se...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer PHASE2 In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma PHASE1 Monoclonal antibodies can locate tumor cells and either kill them or delive...
Show More Location
Children's Oncology Group
Learn More & Join Trial
Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Herbert Irving Comprehensive Cancer Center
Learn More & Join Trial
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma PHASE1 The goal of the Phase I part of this clinical research study is to find the...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive PHASE1 Background:
The National Cancer Institute (NCI) Surgery Branch has develop...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors PHASE1 This is a Phase 1 dose-finding study of FT-516 in combination with monoclon...
Show More Location
University of Minnesota Masonic Cancer Center
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Melanoma PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial